Human endostatin gene transfer, either naked or with liposome, has the same inhibitory effect on growth of mouse liver tumor cells in vivo

World Journal of Gastroenterology

Volumn 10, Issue 19, 2004, Pages 2874-2877

  Ma, Chun Hong ^a   Zhang, Yan ^a   Wang, Xiao Yan ^a   Gao, Li Fen ^a   Liu, Hua ^a   Guo, Chun ^a   Liu, Su Xia ^a   Cao, Ying Lin ^a   Zhang, Li Ning ^a   Sun, Wen Sheng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; DNA; ENDOSTATIN; IMMUNOGLOBULIN G; LIPOSOME; NAKED DNA; PLASMID VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COMPLEX FORMATION; CONTROLLED STUDY; DENSITY; DNA SEQUENCE; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD AND DRUG ADMINISTRATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER CARCINOMA; MOLECULAR CLONING; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; SEQUENCE ANALYSIS; TIME; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 4644352734     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i19.2874     Document Type: Article

References (22)

1. Folkman J. What is the Evidence that tumors are angiogenesis dependent. J Natl Cancer Inst 1990; 82: 4-6
2. Marx J. Angiogenesis. A boost for tumor starvation. Science 2003; 301: 452-454
3. Brem S, Brem H, Folkman J, Finkelstein D, Patz A. Prolonged tumor dormancy by prevention of neovascularization in the vitreous. Cancer Res 1976; 36: 2807-2812
4. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Folkman J, Fukai N, Vasios G, Lane WS, Elynn E, Birkhead JR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285
5. Boehm T, Folkman J, Browder T, O'Reilly MS. Antiangiogenic therapy of experomantal cancer does not induce acquired drug resistance. Nature 1997; 390: 404-407
6. Kerbel RS. A cancer therapy resistant to resistance. Nature 1997; 390: 335-336
7. Ma CH, Sun WS, Zhang LN, Wang XY, Li X. Expression of human endostatin in picha yeast and its inhibition effect on tumor. J Shandong Med University 2001; 39: 334-336
8. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36: 169-180
9. Eder JP Jr, Supko JG, Clark JW, Puchalski TA, Garcia-Carbonero R, Ryan DP, Shulman LN, Proper J, Kirvan M, Rattner B, Connors S, Keogan MT, Janicek MJ, Fogler WE, Schnipper L, Kinchla N, Sidor C, Phillips E, Folkman J, Kufe DW. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol 2002; 20: 3772-3784
10. Wang X, Liu F, Li X, Li J, Xu G. Anti-tumor effect of human endostatin mediated by retroviral gene transfer in nude mice. Chin Med J 2002; 115: 1664-1669
11. Nakashima Y, Yano M, Kobayashi Y, Moriyama S, Sasaki H, Toyama T, Yamashita H, Fukai I, Iwase H, Yamakawa Y, Fujii Y. Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery. Gene Ther 2003; 10: 123-130
12. Li X, Fu GF, Fan YR, Shi CF, Liu XJ, Xu GX, Wang JJ. Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex. World J Gastroenterol 2003; 9: 262-266
13. Bramson JL, Hitt M, Gauldie J, Graham FL. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther 1997; 4: 1069-1076
14. Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999; 401: 517-518
15. Rochlitz CF. Gene therapy of cancer. Drugs Today 2000; 36: 619-629
16. Ota T, Maeda M, Tatsuka M. Cationic liposomes with plasmid DNA influence cancer metastatic capability. Anticancer Res 2002; 22: 4049-4052
17. Kaiser S, Toborek M. Liposome-mediated high-efficiency transfection of human endothelial cells. J Vasc Res 2001; 38: 133-143
18. Clark PR, Stopeck AT, Ferrari M, Parker SE, Hersh EM. Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA. Cancer Gene Ther 2000; 7: 853-860
19. Kim JM, Jeong JG, Ho SH, Hahn W, Park EJ, Kim S, Yu SS, Lee YW, Kim S. Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist. Gene Ther 2003; 10: 1543-1550
20. Imboden M, Shi F, Pugh TD, Freud AG, Thom NJ, Hank JA, Hao Z, Staelin ST, Sondel PM, Mahvi DM. Safety of interleukin-12 gene therapy against cancer: a murine biodistribution and toxicity study. Hum Gene Ther 2003; 14: 1037-1048
21. Fortuin FD, Vale P, Losordo DW, Symes J, DeLaria GA, Tyner JJ, Schaer GL, March R, Snell RJ, Henry TD, Van Camp ], Lopez JJ, Richenbacher W, Isner JM, Schatz RA. One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Am J Cardiol 2003; 92: 436-439
22. Shi F, Rakhmilevich AL, Heise CP, Oshikawa K, Sondel PM, Yang NS, Mahvi DM. Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model. Mol Cancer Ther 2002; 1: 949-957